Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

NCT01100372 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: liposome-encapsulated doxorubicin citrate
PROCEDURE: quality-of-life assessment

Sponsor

Medical University Innsbruck